MANSFIELD, Massachusetts
,
November 21, 2023
(press release)
–
Aclarity – a leader in PFAS (Per- and Polyfluoroalkyl Substances) “forever chemical” destruction – recently announced the successful completion of its Series A funding round, raising $15.9 million. This funding round was led by Aqualateral, with participation from HG Ventures, Bidra Innovation Ventures, Nor’easter Ventures, MassVentures, and Burnt Island Ventures. This funding round builds upon a $3.3 million Seed round secured in 2022, propelling the company into an exciting new commercial expansion and innovation phase. PFAS – often referred to as “forever chemicals” due to their persistent nature in the environment – have become a major concern worldwide due to their detrimental impact on ecosystems and human health. Aclarity’s Octa system provides a sustainable solution for completely eradicating PFAS contaminants, heralding a new era in wastewater treatment and environmental remediation for landfills, water and wastewater treatment plants, and industrial facilities – where PFAS is particularly prevalent. In the last year, Aclarity has deployed mobile systems with full-scale reactors nationwide to destroy PFAS chemicals continuously. And this has allowed the team to successfully treat PFAS in waters ranging from low ng/Ls in tap water all the way to landfill leachate treated by foam fractionation with PFAS concentrations of milligrams per liter, including short-chain compounds like PFBS and demonstrating real-time PFAS destruction in the field. Aclarity’s achievements have gained the attention of groups such as Frost & Sullivan, who awarded Aclarity their Company of the Year Best Practices award for 2023 in the North American PFAS treatment industry. And with the support of this investment, Aclarity has broadened its pipeline across several industries requiring PFAS destruction, such as the waste industry, food and beverage manufacturing, and the pulp and paper industry. The Series A funding round will play a pivotal role in scaling up manufacturing and supply chain capabilities, further increasing market penetration, and advancing partnerships to address PFAS contamination challenges on a global scale. Aclarity’s innovative approach to PFAS destruction has gained attention and support from both investors and environmental advocates alike. And the technology boasts several key advantages, including its cost-effectiveness, environmental safety, and efficiency in eliminating PFAS compounds, offering a sustainable alternative to conventional remediation methods. As Aclarity continues making strides in the fight against PFAS pollution, the company remains committed to its core mission of destroying PFAS to safeguard the environment and public health. And the Series A funding round will be instrumental in driving Aclarity’s growth and accelerating the deployment of its groundbreaking technology to communities and industries in need. KEY QUOTE: “The industry is overwhelmingly demanding a solution to the PFAS problem, responding to existing and pending regulations. We are extremely grateful for the enthusiastic support from our investors and the confidence they have shown in our mission to combat the widespread issue of PFAS contamination. The Series A funding is already enabling us to grow our team, build more PFAS destruction skids and bring them to more communities and industries, ultimately making a lasting positive impact on public health and the environment.” — Julie Bliss Mullen, Founder and CEO of Aclarity “Aclarity has the potential to revolutionize the field of environmental remediation and solve one of the most pressing environmental challenges of our time. We are confident that they will deliver on this promise. The Aclarity team has the capacity and vision to deliver far-reaching transformative results to communities across the globe.” — Jiten Manglani, Aqualateral’s Chief Investment Officer
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
